Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.


- An 'Oncolytic’ (cancer killing) adenovirus is being developed to selectively infect and kill cancer cells!

- Unlike most gene therapy vectors, this virus is equipped to make copies of itself in infected cancer cells and destroy them.

- By deleting adenovirus genes required for replication in normal cells, this oncolytic virus is made tumour-specific!





Find out more about the work of the Gill Hyde Gene Medicine research group at the University of Oxford.